This document discusses cannabidiol (CBD) and the blurring lines between CBD supplements, foods, and pharmaceuticals. It provides estimates for the growing CBD market size between 2018-2022 for hemp-derived and marijuana-derived CBD as well as an FDA-approved CBD pharmaceutical. The document also discusses CBD extraction from hemp, pricing for CBD extracts and isolates, CBD products, labeling requirements, vertically integrated CBD companies, and examples of how supplements and pharmaceuticals use CBD.